Literature DB >> 300210

Immune complexes in cystic fibrosis.

P O Schiotz, N Hoiby, F Juhl, H Permin, H Nielsen, S E Svehag.   

Abstract

Eleven patients with cystic fibrosis (CF) chronically infected with mucoid P. aeruginosa and ten patients without P. aeruginosa infection were examined for occurrence of circulating immune complexes, for immune complex deposits in the dermo-epidermal junction of the skin and for precipitins against P. aeruginosa, S. aureus, H. influenzae and D. pneumoniae antigens. The serum concentrations of haptoglobin, orosomucoid, immunoglobulins, C1q, C3, C4 and total haemolytic complement, antinuclear and rheumatoid factor activities as well as white blood cell counts and erythrocyte sedimentation rates were determined also. The results indicated that 6 patients from the chronically P. aeruginosa infected group, exhibiting a spectrum of serum precipitins against P. aeruginosa antigens, also had immune complexes in the serum, while only one patient (suffering from selective IgA deficiency) in the group without P. aeruginosa infection was positive for soluble immune complexes. Granular deposits of IgM was found in the skin of 10 of the chronically P. aeruginosa infected patients and in 7 of the patients without P. aeruginosa infection. A few pactients in both groups had dermo-epidermal deposits of C1q, C3 or fibrinogen as well. Eight of the patients in the chronically infected group and five in the group without P. aeruginosa infection had organ non-specific antinuclear factors. The haptoglobin levels appeared to be elevated in the chronically infected patients (p less than 0.05). None of the other parameters showed any significant difference between the two groups.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300210     DOI: 10.1111/j.1699-0463.1977.tb03611.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand C        ISSN: 0304-1328


  8 in total

Review 1.  Pathogenesis and management of arthropathy in cystic fibrosis.

Authors:  B M Phillips; T J David
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

Review 2.  Immunological abnormalities in cystic fibrosis: chicken or egg?

Authors:  M E Hodson
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

3.  The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.

Authors:  D B Hornick; R B Fick
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunologic profile in relation to pulmonary function in cystic fibrosis.

Authors:  M K Dasgupta; P Zuberbuhler; A Abbi; F L Harley; N E Brown; K Lam; J B Dossetor; J W Costerton
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

5.  Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.

Authors:  J E Pennington; W F Hickey; L L Blackwood; M A Arnaut
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

6.  Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis.

Authors:  R W Pitcher-Wilmott; R J Levinsky; D J Matthew
Journal:  Arch Dis Child       Date:  1982-08       Impact factor: 3.791

7.  Isolation and characterization of circulating immune complexes in cystic fibrosis.

Authors:  R B Moss; Y P Hsu
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

8.  Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats.

Authors:  J D Klinger; H A Cash; R E Wood; J J Miler
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.